Industry Focus
Healthcare: How’s It Going to Be for AbbVie, Regeneron, Clovis, and More
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:28:04
- Mais informações
Informações:
Sinopse
AbbVie is developing new drugs to sidestep expiring patents on its best-seller, and a new FDA approval could be on deck at Clovis Oncology. Also, how Novartis plans to shake-up a multibillion dollar indication.
